PROVIDER PROFILE · NPI 1922085844

Sylvie Bastadjian-YessayanMD

PRACTICETHE CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITYSee all providers at this practice →

Internal MedicineHarrisburg, NCI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

354

Unique beneficiaries

—

Total services

559

Distinct HCPCS

Medicare payment

$41K

Peer benchmark

Total Medicare services vs. 2,554 Internal Medicine providers in NC — above median (cohort median 687).

PRESCRIBING · PART D · 2024

Total Rx claims

6,159

Beneficiaries

—

Total drug cost

$292K

Distinct drugs

103

Brand share

16.5%

Top prescribed drugs

Omeprazole320 claims

Levothyroxine Sodium311 claims

Atorvastatin Calcium250 claims

Lisinopril226 claims

Simvastatin219 claims

QUALITY · MIPS · 2024

Final MIPS score

100.0

Quality

13.6

Cost

75.5

Improvement activities

40.0

Promoting interop.

99.0

Payment adjustment

1.05%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Sylvie Bastadjian-Yessayan's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 4 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
THE CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY	102	724
Julie Freeland Nurse Practitioner · Concord, NC	24	70
Mark Fromke Diagnostic Radiology · Charlotte, NC	17	28
Charles Mclaughlin Diagnostic Radiology · Charlotte, NC	11	15

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history